109 related articles for article (PubMed ID: 29753083)
1. Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients.
Hu HH; Liu J; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; Quan Y; Xia NS; Chen CJ; Chen PJ; Yang HI
Clin Gastroenterol Hepatol; 2019 Jan; 17(1):172-181.e1. PubMed ID: 29753083
[TBL] [Abstract][Full Text] [Related]
2. Isolated hepatitis B core antibody positive among vaccinated cohort in Malaysia.
Hudu SA; Malik YA; Niazlin MT; Harmal NS; Alshrari AS; Sekawi Z
Ann Saudi Med; 2013; 33(6):591-4. PubMed ID: 24413864
[TBL] [Abstract][Full Text] [Related]
3. ALT to qHBsAg ratio predicts long-term HBsAg seroclearance after entecavir cessation in Chinese patients with chronic hepatitis B.
Leung RH; Hui RW; Mak LY; Mao X; Liu KS; Wong DK; Fung J; Seto WK; Yuen MF
J Hepatol; 2024 Mar; ():. PubMed ID: 38527527
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B surface antigen loss in individuals with chronic hepatitis B virus and HIV-1 infections in Botswana.
Mpebe GGA; Phinius BB; Mutenga S; Baruti K; Bhebhe L; Choga WT; Jongman M; Pretorius-Holme M; Gaolathe T; Mmalane M; Shapiro R; Makhema J; Lockman S; Moyo S; Anderson M; Gaseitsiwe S
AIDS; 2024 Feb; 38(2):153-159. PubMed ID: 37861688
[TBL] [Abstract][Full Text] [Related]
5. Eligibility for hepatitis B antiviral therapy among adults in the general population in Zambia.
Vinikoor MJ; Sinkala E; Kanunga A; Muchimba M; Zanolini A; Saag M; Pry J; Nsokolo B; Chisenga T; Kelly P
PLoS One; 2020; 15(1):e0227041. PubMed ID: 31929556
[TBL] [Abstract][Full Text] [Related]
6. Persistently high HBsAg levels during HBeAg-seropositive stage predict lower risk of hepatocellular carcinoma in chronic hepatitis B patients.
Lin HC; Jeng WJ; Liu J; Pan MH; Lee MH; Batrla-Utermann R; Lu SN; Chen CF; Yang HI; Chen CJ
Aliment Pharmacol Ther; 2024 Apr; 59(8):993-1002. PubMed ID: 38410882
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B seroconversion revisited: new insights into the natural history of acute hepatitis B virus (HBV) infection from quantitative and highly sensitive assays and novel biomarkers.
Kuhns MC; Holzmayer V; McNamara AL; Anderson M; Cloherty GA
Virol J; 2021 Nov; 18(1):235. PubMed ID: 34844619
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of hepatitis B virus infection among general population of Armenia in 2021 and factors associated with it: a cross-sectional study.
Demirchyan A; Dudareva S; Sahakyan S; Aslanyan L; Muradyan D; Musheghyan L; Mozalevskis A; Sargsyants N; Ghukasyan G; Petrosyan V
BMJ Open; 2024 Feb; 14(2):e080281. PubMed ID: 38326250
[TBL] [Abstract][Full Text] [Related]
9. A nation-wide medical record database study: Value of hepatitis B surface antigen loss in chronic hepatitis B patients in Japan.
Okada K; Nakayama Y; Xu J; Cheng Y; Tanaka J
Hepatol Res; 2024 May; ():. PubMed ID: 38748484
[TBL] [Abstract][Full Text] [Related]
10. Rapid Decline Rather Than Absolute Level of HBsAg Predicts Its Seroclearance in Untreated Chronic Hepatitis B Patients From Taiwanese Communities.
Lin HC; Liu J; Pan MH; Lee MH; Batrla-Utermann R; Lu SN; Jeng WJ; Yang HI; Chen CJ
Clin Transl Gastroenterol; 2023 Aug; 14(8):e00586. PubMed ID: 36988242
[TBL] [Abstract][Full Text] [Related]
11. Seroepidemiology of HBV infection among health-care workers in South Sulawesi, Indonesia.
Wijayadi T; Sjahril R; Turyadi ; Ie SI; Wahyuni R; Pattelongi I; Massi MN; Yusuf I; Muljono DH
BMC Infect Dis; 2018 Jun; 18(1):279. PubMed ID: 29914398
[TBL] [Abstract][Full Text] [Related]
12. Plasma interferon-gamma-inducible-protein 10 level as a predictive factor of spontaneous hepatitis B surface antigen seroclearance in chronic hepatitis B patients.
Kan K; Wong DK; Hui RW; Seto WK; Yuen MF; Mak LY
J Gastroenterol Hepatol; 2024 Jan; 39(1):202-209. PubMed ID: 37794699
[TBL] [Abstract][Full Text] [Related]
13. Suggested blood donor deferral strategy regarding hepatitis B infections in China.
Li L; Wang R; Guo J; He L; Liu Z; Qin Q; Zhang J; Wu S; Huang L; Ge H; Liu Z
Transfus Med; 2024 Apr; 34(2):136-141. PubMed ID: 38258949
[TBL] [Abstract][Full Text] [Related]
14. The seroepidemiology of isolated core antibody against hepatitis B among Taiwanese adults - A large hospital-based study.
Kuo TY; Chang JC; Chien YC; Jan CF
J Formos Med Assoc; 2024 Jun; 123(6):693-700. PubMed ID: 37978028
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Serum Anti-HBs Levels and HBsAg/HBeAg Markers in Children and Adolescents: A Cross-Sectional Study.
Niu Z; Zhang P
Viral Immunol; 2024 Mar; 37(2):107-114. PubMed ID: 38447125
[TBL] [Abstract][Full Text] [Related]
16. Functional Cure of Hepatitis B Virus Infection in Individuals With HIV-Coinfection: A Literature Review.
Boyd A; Dezanet LNC; Lacombe K
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372547
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B surface antigen (HBsAg) glycan isomer is predictive of HBsAg seroclearance in patients with chronic hepatitis B.
Ikeda Y; Murata A; Nago H; Yamaguchi M; Om R; Terai Y; Kita Y; Sato S; Sato S; Shimada Y; Genda T
Hepatol Res; 2024 May; ():. PubMed ID: 38804859
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B Core-related Antigen: An Alternative to Hepatitis B Virus DNA to Assess Treatment Eligibility in Africa.
Shimakawa Y; Ndow G; Njie R; Njai HF; Takahashi K; Akbar SMF; Cohen D; Nayagam S; Jeng A; Ceesay A; Sanneh B; Baldeh I; Imaizumi M; Moriyama K; Aoyagi K; D'Alessandro U; Mishiro S; Chemin I; Mendy M; Thursz MR; Lemoine M
Clin Infect Dis; 2020 Mar; 70(7):1442-1452. PubMed ID: 31102406
[TBL] [Abstract][Full Text] [Related]
19. The occurrence of immune-related adverse events is an independent risk factor both for serum HBsAg increase and HBV reactivation in HBsAg-positive cancer patients receiving PD-1 inhibitor combinational therapy.
Zeng Y; Huang J; Pang J; Pan S; Wu Y; Jie Y; Li X; Chong Y
Front Immunol; 2024; 15():1330644. PubMed ID: 38558804
[TBL] [Abstract][Full Text] [Related]
20. CAMP-B score predicts the risk of hepatocellular carcinoma in patients with chronic hepatitis B after HBsAg seroclearance.
Lee HW; Yip TC; Wong VW; Lim YS; Chan HL; Ahn SH; Wong GL; Choi J
Aliment Pharmacol Ther; 2024 May; 59(10):1223-1235. PubMed ID: 38425096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
